21 reports

Also, this disorder has a strong association with asthma.

  • Allergy Drug
  • Ear Disease
  • World
  • Novartis AG
  • Sanofi S.A.
  • Products under Development by Companies, H1 2018
  • Number of Products under Development by Indication, H1 2018

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • Molecular Diagnostic
  • Therapy
  • Sensorion S.A.
  • Pipeline by Novartis AG, H2 2018
  • Pipeline by Sensorion SA, H2 2017

The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Ear Disease
  • Molecular Diagnostic
  • World
  • Product Initiative
  • Sensorion S.A.
  • Deal Rationale
  • Parent

Palau will continue the development of UR-## for the treatment of asthma.

  • Ear Disease
  • France
  • Company
  • Deals & Alliance
  • Sensorion S.A.
  • TINNITUS - PIPELINE BY AUDIOCURE PHARMA GMBH, H2 2018
  • TINNITUS - PIPELINE BY AURIS MEDICAL HOLDING AG, H2 2018

Its dexpramipexole is an anti-inflammatory therapeutic for moduling white blood cells such as eosinophils and orally bioavailable small molecule, which is used for the treatment of asthma.

  • Ear Disease
  • Therapy
  • United States
  • World
  • Product Initiative

NO has a solid place in asthma management.

  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • Thermo Fisher Scientific, Inc.
  • Jan 17, 2018: ADM Tronics Presents Outlook for 2018

Alvio™, a respiratory therapy and training platform for patients who suffer from respiratory indications such as COPD, Asthma as well as for athletic training.

  • Ear Disease
  • Medical Equipment
  • United States
  • Company Financials
  • ADM Tronics Unlimited, Inc.

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Clinical Trial
  • Ear Disease
  • Pathology
  • Therapy
  • GlobalData's company
  • UR-63325 - Drug Profile

In animal asthma models, the molecule shows very good efficacy in both inflammatory and respiratory parameters.

  • Ear Disease
  • Molecular Diagnostic
  • Turkey
  • World
  • Product Initiative
  • TINNITUS - PIPELINE BY AUDIOCURE PHARMA GMBH, H1 2018
  • TINNITUS - PIPELINE BY AURIS MEDICAL HOLDING AG, H1 2018

The company' s lead product candidate, dexpramipexole, is an orally bioavailable small molecule which is used for the treatment of asthma, other eosinophilassociated disorders, and for amyotrophic lateral sclerosis (ALS).

  • Ear Disease
  • United States
  • World
  • Product Initiative
  • Auris Medical Holding AG
  • Meniere Disease - Companies Involved in Therapeutics Development
  • Meniere Disease - Pipeline by Orbis Biosciences Inc, H2 2018

Following the lead-in period, eligible subjects will be randomized ##:## to a single intratympanic injection of ## mg OTO-## or placebo (gel vehicle).

  • Ear Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • Otonomy, Inc.
  • Meniere Disease - Pipeline by Orbis Biosciences Inc, H1 2018

Following an initial one month lead-in period, eligible subjects were randomized ##:## to a single intratympanic injection of OTIVIDEX or placebo.

  • Ear Disease
  • Pharmaceutical
  • United States
  • Product Initiative
  • Otonomy, Inc.

UR-## IS A H## RECEPTOR ANTAGONIST WHICH IS BEING EVALUATED FOR RESPIRATORY CONDITIONS SUCH AS ASTHMA.

  • Ear Disease
  • United States
  • AudioCure Pharma GmbH
  • Autifony Therapeutics Limited
  • Cochlear Limited
  • FEATURED NEWS & PRESS RELEASES

IN ELDERLY PATIENTS AND THOSE WITH COPD OR ASTHMA, COMPARED TO MOXIFLOXACIN, THE NUMBER OF RESPONDERS ON SOLITHROMYCIN WAS NUMERICALLY GREATER. ##-Aug-2015 Cempra, Inc. announced that the U. S.

  • Anti-Infective
  • Ear Disease
  • United States
  • Product Initiative
  • Cempra, Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.
  • Latest Clinical Trials News on Otitis Media

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Ear Disease
  • Hospital
  • Therapy
  • World

In elderly patients and those with COPD or asthma, compared to moxifloxacin, the number of responders on solithromycin was numerically greater. disclosed. ##-Aug-2015 Cempra, Inc. announced that the U. S.

  • Anti-Infective
  • Ear Disease
  • United States
  • Product Initiative
  • Cempra, Inc.
  • ACUTE SENSORINEURAL HEARING LOSS - PIPELINE BY ORBIS BIOSCIENCES INC, H2 2016
  • NORDMARK ARZNEIMITTEL GMBH & CO. KG

The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Ear Disease
  • United States
  • World
  • Product Initiative
  • Auris Medical Holding AG
  • Pipeline by Xigen SA, H2 2017

Patients were randomized to receive AM- ## ##. ## mg/ mL, ##. ## mg/ mL or placebo in a ##:##:## ratio.

  • Ear Disease
  • Health Services
  • Hospital
  • United States
  • Product Initiative

Patients were randomized to receive AM- ## ##. ## mg/ mL, ##. ## mg/ mL or placebo in a ##:##:## ratio.

  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • Therapy
  • United States
  • Product Initiative

The poster presentation, reported on the cardiac effects of nVNS in asthma patients using nVNS to treat acute bronchospasm.

  • Cardiovascular Disease
  • Clinical Trial
  • Ear Disease
  • Therapy
  • GlobalData's company
  • PIPELINE BY KNOPP BIOSCIENCES LLC, H2 2016

The molecules developed by Companies in Phase II, Preclinical, Discovery and Unknown stages are ##, ##, ## and ## respectively.

  • Ear Disease
  • Neurological Disorder
  • Therapy
  • United States
  • Company Operations